Skip to main content
OpenTrials
Completed

NCT Number: NCT00838500

THERMES ET VEINES: Spa for Prevention of Leg Ulcers

The main objective of this study is to test the hypothesis that a 3 week intensive course of spa therapy can reduce the risk of leg ulcers in patients with advanced chronic venous insufficiency (C4a-b and C5 of the CEAP classification) at one year.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Cabinet médical, Albertville, France

Loading trial locations.

About this study

Chronic venous insufficiency affects to differing extents half of the French population. The most advanced forms, with skin changes (CEAP clinical classes C4-5-6) affect 5% of the population and are those most often indicated for spa treatment. A venous condition is recognized as justifying spa therapy by 12 spa resorts in France. However, no specific or global benefit has been clearly scientifically shown for such therapy. One methodologically sound study (Carpentier 2009) demonstrated a benefit of spa therapy using a non-clinical intermediate endpoint (severity of skin changes). No study has shown efficacy of spa therapy in the primary and secondary prevention of the major and most common complication of advanced chronic venous insufficiency: leg ulcers.

Vascular hemodynamics and in particular venous return from the lower limbs is subject to the laws of physics. Thus, the roles of the calf muscle venous pump and hydrostatic pressure in venous insufficiency rationalizes the use of balneotherapy techniques in the management of this pathology.

The spa therapy techniques used in the context of venous insufficiency have well-defined physiopathic targets and the hemodynamic and microcirculatory effects of some of them have been demonstrated. The high degree of satisfaction of patients taking the waters annually for venous conditions indirectly testifies to their enhanced well-being. Among venous indications, the prevention of post-thrombotic syndrome is one of the best recognized by the medical profession.Nevertheless, there has been no real validation of this indication with an acceptable methodology that meets the canons of evidence based medicine.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Both sexes, more than 18 years old patients with a phlebological indication of spa treatment, with advanced chronic venous insufficiency, class C4a, or b or C5 of CEAP classification (leg ulcers must be healed since 3 months at least)
  • Available for a spa treatment during 18 days (immediate or late spa)and a follow-up period of 18 months
  • Voluntary to participate to the study,informed consent form signed after appropriate information
  • Affiliation to the social security system or equivalent

Exclusion criteria

  • Pregnancy, parturient or breast feeding
  • No psychiatric illness or social situation that would preclude study compliance
  • Leg ulcer in progress
  • Leg ulcer healed for less than 3 months
  • Refusal to consent
  • Refusal of spa treatment
  • Contra-indication of spa treatment(cancer in progress, psychiatric disorders, immunodeficiency)
  • Arteriopathy of lower limb with an Ankle Brachial Pressure Index (ABPI)< 0.7, symptomatic neuropathy, erysipelas within 5 years prior to inclusion
  • Surgical or endovascular treatment of the venous disease planned during the first year or during the six months prior to inclusion
  • No previous phlebological spa treatment within 6 months prior to inclusion

Treatment and study plan

Immediate spa treatment

Drug

1st year, soon after randomization: Spa treatment of 18 days. Spa treatment : the most adapted to the concerned pathology and common to all of spa resorts(walk in a specially pool, whirlpool bath with automatic air and water massages cycles, massaging shower...)

Late spa treatment

Drug

2nd year, soon after 12 months visit: Spa treatment of 18 days. Spa treatment : the most adapted to the concerned pathology and common to all of spa resorts(walk in a specially pool, whirlpool bath with automatic air and water massages cycles, massaging shower...)

Primary outcomes

  1. Occurrence of a leg ulcer within the year following the inclusion. The ulcer will be classified C5 of CEAP (healed ulcer) or C6 (non healed ulcer)at the follow up visit.

    Time frame: 1 year

Secondary outcomes

  1. Healing time of the leg ulcers within the first year

    Time frame: 12 months

  2. Quality of life: Euroqol EQ 5D, CIVIQ2 Scale

    Time frame: Inclusion - 6 months - 12 months- 18 months

  3. Aggravation level defined as at least 20% increase of the modified Rutherford score and mean comparison of this score at 1 year

    Time frame: Inclusion - 12 months - 18 months

  4. Visual analog scale for leg symptoms

    Time frame: Monthly (until 18 months)

  5. Evaluation of the costs involved by the venous insufficiency at 1 year (treatments, physical treatments, hospitalization)

    Time frame: Inclusion - 6, 12 and 18 months

Sponsors and collaborators

Lead sponsor

Association Francaise pour la Recherche Thermale

Other

Collaborators

  • Floralis
  • Université Joseph Fourier

Registry information

Official study title

Evaluation of the Efficacy of Spa Treatment for Prevention of Leg Ulcers in Advanced Chronic Venous Insufficiency.

Important dates

Study start
2008
Primary completion
2010
Study completion
2011
First posted
Feb 6, 2009
Registry last updated
Oct 1, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.